LifeMD, Inc. (LFMDP) intrinsic value & 10-year financials
LifeMD, Inc. (LFMDP) has a Graham intrinsic value of $8.30 per share. Over the last 10 fiscal years revenue grew 49.4% a year to $194.1M, with an average return on invested capital of 976.7%.
- Graham intrinsic value
- $8.30
- Revenue (FY2025)
- $194.1M
- Revenue growth (10-yr CAGR)
- 49.4%
- ROIC (10-yr avg)
- 976.7%
- Free cash flow (FY2025)
- $6.4M
LFMDP 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $194.1M | $14.4M | $0.25 | $6.4M | -4.0% | 36.3% |
| FY2024 | $212.5M | -$18.9M | -$0.60 | $16.0M | -7.6% | 50.9% |
| FY2023 | $152.5M | -$20.6M | — | $8.6M | -9.5% | 70.3% |
| FY2022 | $119.0M | -$45.5M | — | -$23.3M | -36.5% | 296.3% |
| FY2021 | $92.9M | -$60.9M | — | -$33.3M | -58.5% | 389.9% |
| FY2020 | $37.3M | -$58.6M | — | — | -155.0% | 980.9% |
| FY2019 | $83.6K | -$3.1M | — | — | -3458.4% | 8223.5% |
| FY2018 | $42.5K | -$1.2M | — | — | -4836.3% | -163.3% |
| FY2017 | $23.2K | -$1.2M | -$0.03 | — | -4601.4% | -374.4% |
| FY2016 | $5.2M | -$1.1M | -$0.03 | — | -22.4% | 256.8% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
LifeMD, Inc. is a consistent compounder, expanding top-line revenue at 49.4% annually over the past decade.
LifeMD, Inc. has earned high returns on invested capital, averaging 25.4% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
LifeMD, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, LifeMD, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $8.30 per share.